United Biotech (P) Ltd.


Choriotec
 

Composition

Human Chorionic Gonadotrphin
2000IU/5000IU/10000IU Vials

Pharmaceutical form

Vials

Therapeutic Indications

FEMALE
: Anovulatory infertility

Superovulation

Corpus Luteum Insufficiency

Habitual Abortion

Threatened Abortion

MALE
: Hypogonadotrophic hypogonadism

Crypto-orchidism

Oligoasthenospermia

Azoospermia

Posology and method of administration

FEMALE
:
Anovulatory infertility
: 5,000 I.U. or 10,000 I.U. given 24 - 48 hrs.
Superovulation
: 10,000 IU of Choriotec is given in one single injection.
Corpus luteum Insufficiency
: Up to 5000 I.U administered on the 5th day after ovulation and the same dose again on 9th day.
Habitual abortion / Threatened abortion
: Initial dose : 10,000 I.U.

Maintenance dose: 5000 I.U. twice weekly until (including) the 14th week of gestation.
MALE
:
Hypogonadotrophic
/Hypogonadism
: Choriotec 2000 I.U. should be given 2-3 times per week.
Crypto-orchidism
: Choriotec, 1000 I.U should be given on alternate days for several weeks .
Oligo-asthenospermia & azoospermia
: Choriotec 2000 I.U. should be given every 5 days and Menotec 75-150 I.U. 3 times a week for three

Interaction with other pharmaceuticals

Not Available

Pregnancy and lactation

Not Available

Effects on abilities

Not Available

Overdose

Not Available

Pharmacological Properties

Not Available

Excipients

Not Available

Shelf life

Not Available

Storage

Not Available

Packaging

1 vial of 2000 IU
1 Vial of 5000 IU
1 Vial of 10000 IU